The Company:
With deep expertise in chemistry, Nuvalent is working to create selective medicines designed with the goal to address the needs of patients with cancer. Nuvalent is an exciting early-stage company, bringing together experienced scientists and industry veterans with a proven track record in drug discovery, oncology drug development, and company building.
The Role:
Reporting to the Vice President, Sales, the Director of Sales Training will develop and execute the sales training strategy in preparation for our first commercial launch. This individual will be responsible for designing and delivering a best-in-class onboarding and continuous learning program to ensure the sales team is fully equipped to communicate the clinical value, competitive differentiation, and market positioning of our medicines. The ideal candidate has a strong background in oncology, biotech sales training, launch experience, and the evolving NSCLC treatment landscape.
Responsibilities:
• Develop and implement a comprehensive sales training curriculum to prepare the field sales team for product launch, ensuring strong scientific, clinical, and competitive acumen.
• Lead onboarding for new sales hires, ensuring rapid ramp-up on disease state, product knowledge, and sales effectiveness.
• Design and facilitate workshops, role-playing exercises, and certification programs to enhance selling skills and engagement with oncologists.
• Collaborate with cross-functional teams (Marketing, Medical Affairs, Market Access) to create training materials, including disease state education, clinical data presentations, objection handling, and competitive messaging.
• Partner with Sales Leadership and Commercial Operations to develop and execute training programs aligned with key launch milestones and go-to-market strategy.
• Establish a continuous learning framework, including virtual and live training, sales meetings, and field coaching support to reinforce knowledge post-launch.
• Monitor the competitive landscape, ensuring the sales team is equipped with the latest insights on ROS1/ALK NSCLC treatment paradigms and evolving standards of care.
• Assess training effectiveness through competency evaluations, sales team feedback, and impact on field execution, adjusting strategies as needed.
• Collaborate with commercial leadership in the planning and content development of sales meetings, including national regional meetings.
• Identify vendor partners to support training material development and meeting logistics.
• Work closely with Marketing, Regulatory, Legal, and Medical for review of training materials.
Competencies include:
• Foster a culture of empowerment, collaboration, and a focus on patient impact.
• Strong scientific and clinical orientation, comfortable with data, and ability to distill complex clinical information into business implications and credible narrative with internal and external stakeholders.
• Strong knowledge of adult learning principles, instructional design, and content development platforms.
• Exceptional communication and influence skills, with the ability to inspire confidence and work successfully with varied stakeholders including KOLs and organized customers.
• Drives for results and nurtures a performance-based culture of continuous improvement, addressing concerns and conflict proactively.
• Characteristics include being entrepreneurial, collaborative, and an energetic self-starter with strong interpersonal and analytical skills.
• Demonstrated organizational skills to manage multiple projects simultaneously, prioritize projects effectively and communicate at all levels within the company.
Qualifications:
• Bachelor’s degree required, MBA or equivalent degree preferable.
• 8+ years biopharma experience including oncology launch experience, biotech experience preferably.
• 5+ years of US oncology sales training experience. Additional experience in oncology sales or sales leadership is desirable.
• Demonstrated organizational skills to manage multiple projects simultaneously, prioritize projects effectively and communicate at all levels within the company.
• Strong knowledge of adult learning principles, instructional design, and content development platforms.
• Strong written and verbal communication skills (including presentation skills).
• Up to 25% domestic travel.
Nuvalent provides equal employment opportunities (EEO) to all employees and applicants for employment without regard to religion, race, creed, color, sex, sexual orientation, alienage or citizenship status, national origin, age, marital status, pregnancy, disability, veteran or military status, predisposing genetic characteristics or any other characteristic protected by applicable federal, state or local law.
Nuvalent is aware that many companies are dealing with fraudulent job postings on third-party employment search sites and/or individual(s) or entities claiming to be employees of such companies. Those involved are offering fraudulent employment opportunities to applicants, often asking for sensitive personal and financial information, and using such information for criminal activities.
Please be advised that all legitimate correspondence from a Nuvalent employee will come from "@nuvalent.com" email accounts. Automated system response emails from our Greenhouse applicant tracking system come from a “[email protected]” email address. There are no variations of these email addresses and Nuvalent would not request personal and/or financial information via email. Job opportunities would only be extended after a completed job application is submitted by a candidate and a thorough interview process including 1:1 and/or group interviews via phone, video conferencing and/or in-person.
If you believe you have been contacted by anyone misrepresenting themselves as an employee of Nuvalent, please contact Nuvalent at 857-357-7000. Thank you.
What We Do
Nuvalent is creating precisely targeted therapies for patients with cancer designed to overcome the limitations of existing therapies for clinically proven kinase targets. Leveraging deep expertise in structure-based design, Nuvalent develops innovative small molecules with exquisite target selectivity to overcome resistance, minimize adverse events, and drive more durable responses. Nuvalent is advancing a robust pipeline with parallel lead programs in ROS1-positive and ALK-positive NSCLC, along with multiple discovery-stage research programs. To learn more, visit www.nuvalent.com.
